慢性肝病患者肝自主神经系统病理生理作用及其机制研究进展

doi:10.3969/j.issn.1672-5069.2026.05.002

摘要/Abstract

关键词: 肝细胞癌, 肝硬化, 代谢功能障碍相关脂肪性肝病, 肝再生, 自主神经系统

Key words: Hepatoma, Liver cirrhosis, Metabolic dysfunction-associated steatotic liver disease, Liver regeneration, Autonomic nervous system

王佳颖, 张濛销, 汤善宏. 慢性肝病患者肝自主神经系统病理生理作用及其机制研究进展[J]. 实用肝脏病杂志, 2026, 29(5): 645-648.

Wang Jiaying, Zhang Mengxiao, Tang Shanhong. Pathophysiological roles and its mechanisms of hepatoautonomic nervous system in patients with chronic liver diseases[J]. Journal of Practical Hepatology, 2026, 29(5): 645-648.

参考文献

[1] Miller B M, Oderberg I M, Goessling W. Hepatic nervous system in development, regeneration, and disease. Hepatology, 2021, 74(6):3513-3522.
[2] Luo Q, Liu P, Dong Y, et al. The role of the hepatic autonomic nervous system. Clin Mol Hepatol, 2023, 29 (4): 1052-1055.
[3] Nagayama I, Kamimura K, Owaki T, et al. Complementary role of peripheral and central autonomic nervous system on insulin-like growth factor-1 activation to prevent fatty liver disease. Hepatol Int, 2023, 18 (1): 155-167.
[4] Adori C, Daraio T, Kuiper R, et al. Disorganization and degeneration of liver sympathetic innervations in nonalcoholic fatty liver disease revealed by 3D imaging. Sci Adv, 2021, 7(30):eabg5733.
[5] Kawaguchi T, Tsutsumi T, Nakano D, et al. MAFLD: Renovation of clinical practice and disease awareness of fatty liver. Hepatol Res, 2021, 52 (5): 422-432.
[6] Ghosh P M, Shu Z J, Zhu B, et al. Role of β-adrenergic receptors in regulation of hepatic fat accumulation during aging. J Endocrinol, 2012, 213(3):251-261.
[7] Hurr C, Simonyan H, Morgan D A, et al. Liver sympathetic denervation reverses obesity-induced hepatic steatosis. J Physiol, 2019, 597(17):4565-4580.
[8] Amir M, Yu M, He P,et al. Hepatic autonomic nervous system and neurotrophic factors regulate the pathogenesis and progression of non-alcoholic fatty liver disease. Front Med (Lausanne), 2020, 7:62.
[9] 董桂芳,陈杰,李雪梅.自主神经调控参与非酒精性脂肪肝发生发展的相关机制研究进展.北京医学, 2022, 44(10):920-922.
[10] Zheng L, Gong L, Cai X, et al. Sympathetic blockage attenuates fasting-induced hepatic steatosis. Neuroreport, 2022, 33 (17): 763-770.
[11] Fei B, Zhao Y, Wang J,et al. Leveraging adrenergic receptor blockade for enhanced nonalcoholic fatty liver disease treatment via a biomimetic nanoplatform. J Nanobiotechnology, 2024, 22(1):591.
[12] Adori M, Bhat S, Gramignoli R,et al. Hepatic innervations and nonalcoholic fatty liver disease. Semin Liver Dis, 2023, 43(2):149-162.
[13] Xue J, Jiang T, Humaerhan J,et al. Impact of liver sympathetic nervous system on liver fibrosis and regeneration after bile duct ligation in rats. J Mol Neurosci, 2024, 74(1):4.
[14] Medina Pizaño M Y, Loera Arias M J, Montes de Oca Luna R, et al. Neuroimmunomodulation of adrenoblockers during liver cirrhosis: modulation of hepatic stellate cell activity. Ann Med, 2023, 55(1):543-557.
[15] 陈相林,丁珺,程翅,等.交感神经系统在肝硬化及其并发症中的作用研究进展.中国医学科学院学报, 2024, 46(1):128-134.
[16] Mizuno K, Haga H, Okumoto K, et al. Intrahepatic distribution of nerve fibers and alterations due to fibrosis in diseased liver. PLoS One, 2021, 16(4): e0249556.
[17] Tanaka M, Jeong J, Thomas C,et al. The sympathetic nervous system promotes hepatic lymphangiogenesis, which is protective against liver fibrosis. Am J Pathol, 2023, 193(12):2182-2202.
[18] Li W, Zhang J, Gao Y, et al. Nervous system in hepatocellular carcinoma: correlation, mechanisms, therapeutic implications, and future perspectives. Biochim Biophys Acta Rev Cancer, 2025, 1880 (3): 189345.
[19] Lelou E, Corlu A, Nesseler N, et al. The role of catecholamines in pathophysiological liver processes. Cells, 2022, 11(6):1021.
[20] Mandal S K, Yadav P, Sheth R A. The neuroimmune axis and its therapeutic potential for primary liver cancer. Int J Mol Sci, 2024, 25(11):6237.
[21] Azzu V, Vacca M, Virtue S, et al. Adipose tissue-liver cross talk in the control of whole-body metabolism: implications in nonalcoholic fatty liver disease. Gastroenterology, 2020, 158 (7): 1899-1912.
[22] Hwang J, Okada J, Liu L, et al. The development of hepatic steatosis depends on the presence of liver-innervating parasympathetic cholinergic neurons in mice fed a high-fat diet. PLoS Biol, 2024, 22(10): e3002865.
[23] Li Y, Xu Z, Yu Y, et al. The vagus nerve attenuates fulminant hepatitis by activating the Src kinase in Kuppfer cells. Scand J Immunol, 2014, 79 (2): 105-112.
[24] Ahmed O, Caravaca A S, Crespo M, et al. Hepatic stellate cell activation markers are regulated by the vagus nerve in systemic inflammation. Bioelectron Med, 2023, 9 (1): 6.
[25] Luo L, Xu T, Wang P,et al. Expression of muscarinic acetylcholine receptors in hepatocytes from rat fibrotic liver. Exp Toxicol Pathol, 2017, 69(2):73-81.
[26] Trucas M, Barry D, Conroy M J, et al. Liver innervation in health and disease: neuroimmune-neurovascular interface and future therapeutic implications. Biomedicines, 2025, 13(12):3091.
[27] Trucas M, Kowalik M A, Boi M, et al. The density of hepatic autonomic innervation differs between compensatory and direct hyperplasia rat models. J Peripher Nerv Syst, 2023, 28(1):98-107.
[28] Bauer K C, Ghabra S, Ma C, et al. Liver cancer neuroscience: regulating liver tumors via selective hepatic vagotomy. Methods Protoc, 2024, 7(6):99.
[29] 吴红,刘林,汤善宏.重视肝再生能力在肝衰竭预后评估中的价值.西南医科大学学报, 2024, 47(1):25-28.
[30] 陈美娟,李雪,汤善宏.多维度评估肝功能在肝衰竭患者预后中研究进展.临床军医杂志, 2023, 51(9):901-903+907.
[31] Wang X, Shen C, Yang J,et al. Alpha-fetoprotein as a predictive marker for patients with hepatitis B-related acute-on-chronic liver failure. Can J Gastroenterol Hepatol, 2018, 2018:1232785.
[32] Wang X, Sun M, Yang X,et al. Value of liver regeneration in predicting short-term prognosis for patients with hepatitis B-related acute-on-chronic liver failure. Biomed Res Int, 2020, 2020:5062873.
[33] Kim T H, Um S H, Lee Y S, et al. Determinants of re-compensation in patients with hepatitis B virus-related decompensated cirrhosis starting antiviral therapy. Aliment Pharmacol Ther, 2022, 55(1):83-96.
[34] Oben J A, Roskams T, Yang S, et al. Sympathetic nervous system inhibition increases hepatic progenitors and reduces liver injury. Hepatology, 2003, 38 (3): 664-673.
[35] Soeda J, Mouralidarane A, Ray S, et al. Theβ-adrenoceptor agonist isoproterenol rescues acetaminophen-injured livers through increasing progenitor numbers by Wnt in mice. Hepatology, 2014, 60 (3): 1023-1034.
[36] Song Z, Wu J, Jiang T, et al. The protective effect of the vagus nerve-α7nAChR-IL-22 pathway on acute liver injury. Cytokine, 2024, 186:156840.